Questions and Answers Related to the Prebiotic Production of Oligonucleotide Sequences from 3’,5’ Cyclic Nucleotide Precur- Life Sors
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Oligomeric A2 + B3 Approach to Branched Poly(Arylene Ether Sulfone)
“One-Pot” Oligomeric A 2 + B 3 Approach to Branched Poly(arylene ether sulfone)s: Reactivity Ratio Controlled Polycondensation A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By ANDREA M. ELSEN B.S., Wright State University, 2007 2009 Wright State University WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES June 19, 200 9 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY Andrea M. Elsen ENTITLED “One-Pot” Oligomeric A2 + B3 Approach to Branched Poly(arylene ether sulfone)s: Reactivity Ratio Controlled Polycondenstation BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science . _________________________ Eric Fossum, Ph.D. Thesis Director _________________________ Kenneth Turnbull, Ph.D. Department Chair Committee on Final Examination ____________________________ Eric Fossum, Ph.D. ____________________________ Kenneth Turnbull, Ph.D. ____________________________ William A. Feld, Ph.D. ____________________________ Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies Abstract Elsen, Andrea M. M.S., Department of Chemistry, Wright State University, 2009. “One-Pot” Oligomeric A 2 + B 3 Approach to Branched Poly(arylene ether sulfone)s: Reactivity Ratio Controlled Polycondensation The synthesis of fully soluble branched poly(arylene ether)s via an oligomeric A 2 + B 3 system, in which the A 2 oligomers are generated in situ, is presented. This approach takes advantage of the significantly higher reactivity toward nucleophilic aromatic substitution reactions, NAS, of B 2, 4-Fluorophenyl sulfone, relative to B 3, tris (4-Fluorophenyl) phosphine oxide. The A 2 oligomers were synthesized by reaction of Bisphenol-A and B 2, in the presence of the B 3 unit, at temperatures between 100 and 160 °C, followed by an increase in the reaction temperature to 180 °C at which point the branching unit was incorporated. -
And Ph-Dependent Oligomerization of the Thrombin-Derived C-Terminal Peptide TCP-25
biomolecules Article Concentration- and pH-Dependent Oligomerization of the Thrombin-Derived C-Terminal Peptide TCP-25 Ganna Petruk 1,* , Jitka Petrlova 1, Firdaus Samsudin 2 , Rita Del Giudice 3 , Peter J. Bond 2,4 and Artur Schmidtchen 1,5,6 1 Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, 22241 Lund, Sweden; [email protected] (J.P.); [email protected] (A.S.) 2 Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore; [email protected] (F.S.); [email protected] (P.J.B.) 3 Research Centre for Biointerfaces, Department of Biomedical Sciences and Biofilms, Malmö University, 20506 Malmö, Sweden; [email protected] 4 Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore 5 Copenhagen Wound Healing Center, Bispebjerg Hospital, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark 6 Dermatology, Skane University Hospital, 22185 Lund, Sweden * Correspondence: [email protected]; Tel.: +46-46-22-23-315 Received: 18 October 2020; Accepted: 9 November 2020; Published: 19 November 2020 Abstract: Peptide oligomerization dynamics affects peptide structure, activity, and pharmacodynamic properties. The thrombin C-terminal peptide, TCP-25 (GKYGFYTHVFRLKKWIQKVIDQFGE), is currently in preclinical development for improved wound healing and infection prevention. It exhibits turbidity when formulated at pH 7.4, particularly at concentrations of 0.3 mM or more. We used biochemical and biophysical approaches to explore whether the peptide self-associates and forms oligomers. The peptide showed a dose-dependent increase in turbidity as well as α-helical structure at pH 7.4, a phenomenon not observed at pH 5.0. -
Structural Mechanisms of Oligomer and Amyloid Fibril Formation by the Prion Protein Cite This: Chem
ChemComm View Article Online FEATURE ARTICLE View Journal | View Issue Structural mechanisms of oligomer and amyloid fibril formation by the prion protein Cite this: Chem. Commun., 2018, 54,6230 Ishita Sengupta a and Jayant B. Udgaonkar *b Misfolding and aggregation of the prion protein is responsible for multiple neurodegenerative diseases. Works from several laboratories on folding of both the WT and multiple pathogenic mutant variants of the prion protein have identified several structurally dissimilar intermediates, which might be potential precursors to misfolding and aggregation. The misfolded aggregates themselves are morphologically distinct, critically dependent on the solution conditions under which they are prepared, but always b-sheet rich. Despite the lack of an atomic resolution structure of the infectious pathogenic agent in prion diseases, several low resolution models have identified the b-sheet rich core of the aggregates formed in vitro, to lie in the a2–a3 subdomain of the prion protein, albeit with local stabilities that vary Received 17th April 2018, with the type of aggregate. This feature article describes recent advances in the investigation of in vitro Accepted 14th May 2018 prion protein aggregation using multiple spectroscopic probes, with particular focus on (1) identifying DOI: 10.1039/c8cc03053g aggregation-prone conformations of the monomeric protein, (2) conditions which trigger misfolding and oligomerization, (3) the mechanism of misfolding and aggregation, and (4) the structure of the misfolded rsc.li/chemcomm intermediates and final aggregates. 1. Introduction The prion protein can exist in two distinct structural isoforms: a National Centre for Biological Sciences, Tata Institute of Fundamental Research, PrPC and PrPSc. -
On the Mechanism of Oligomer Formation in Condensations of Alkyl Cyanoacetates with Formaldehyde
Polymer Journal, Vol. 13, No. 10, pp 975-978 (1981) NOTE On the Mechanism of Oligomer Formation in Condensations of Alkyl Cyanoacetates with Formaldehyde J. M. ROONEY Loctite (Ireland) Limited, Whitestown Industrial Estate, Ta//aght, Co. Dublin. Ireland. (Received December II, 1980) KEY WORDS Alkyl Cyanoacetates I Formaldehyde / Condensation Anionic Polymerization I Cyanoacrylate I Chain Transfer I Industrial synthetic routes to the production of Since the apparent activation energy of the over alkyl cyanoacrylate monomers frequently involve all process was found to be similar to that of the base-catalyzed condensations of alkyl cyanoacetates condensation of diethyl dicyanoglutarate with for with formaldehyde to form low molecular weight maldehyde, the addition of diethyl dicyanoglutarate polymers. 1 Early studies attributed polymer for to formaldehyde is assumed to be the rate mation to a stepwise condensation2 of the form,3.4 determining step. CN CN I I CH2 + HCHO _..... CHCH20H I I COOR COOR CN CN CN CN I I I I CHCH2 0H + CH2 -----. CH-CH2-CH + H2 0 I I I I COOR COOR COOR COOR CN CN CN CN I I I I CH-CH2-CH + HCHO -----. CH-CH2-C-CH20H I I I I COOR COOR COOR COOR CN CN CN I I I CH-CH2-C-CH20H + CH2 etc. I I I COOR COOR COOR Subsequently, a kinetic study of the reaction of philic displacement of the hydroxyl group by cya formaldehyde with methyl cyanoacetate5 yielded noacetate anion. Instead, it is postulated that evidence that methyl cyanoacrylate monomer is an essential step in water evolution is the formation of intermediate in oligomer formation. -
Watson Andcrick1 Consists of Two Polynucleotide Chains, Which Are
73474CHEMISTRY: DONOHUE AND STENT PiRoc. N. A. S. 2 E. Klenk, Z. physiol. Chem., 268, 50,1941. 3 K. Meyer, Advances in Protein Chemistry, 2, 249, 1945. 4K. Meyer, E. Chaffee, G. L. Hobby, and M. H. Dawson, J. Exptl. Med., 73, 309, 1941. 5 M. M. Rapport, A. Linker, and K. Meyer, J. Biol. Chem., 192, 283, 1951. 6 J. Werner and L. Odin, Acta Soc. med. Upsaliensis, 57, 230, 1952. 7 L. A. Elson and W. T. J. Morgan, Biochem. J., 27, 1924, 1933. 8 S. Gardell, Acta chem. Scand., 7, 207, 1953. 9 M. McLeod and R. Robison, Biochem. J., 23, 517, 1929. 10 0. Schales and S. S. Schales, Arch. Biochem., 8, 285, 1948. 11 We are indebted to Dr. Calderon Howe, of the Department of Microbiology, Columbia Uni- versity College of Physicians and Surgeons, New York, for these studies. 12 We wish to thank Dr. Baruch S. Blumberg for performing the ultracentrifugation studies. 13 G. Blix, E. Lindberg, L. Odin, and I. Werner, Nature, 175, 340, 1955. 14 W. T. J. Morgan and L. A. Elson, Biochem. J., 28, 988, 1934. 16 A. Gottschalk, Yale J. Biol. and Med., 28, 525, 1956. 16 E. Klenk, H. Faillard, F. Weygand, and H. H. Schbne, Z. physiol. Chem., 304, 35, 1956. 17 J. S. D. Bacon and J. Edelman, Biochem. J., 48, 114, 1951. 18 S. M. Partridge, Biochem. J., 42, 238, 1948. 19 P. J. Stoffyn and R. W. Jeanloz, Arch. Biochem., 52, 373, 1954. 20 J. Immers and E. Vasseur, Acta chem. Scand., 6, 363, 1952. -
Chapter 23 Nucleic Acids
7-9/99 Neuman Chapter 23 Chapter 23 Nucleic Acids from Organic Chemistry by Robert C. Neuman, Jr. Professor of Chemistry, emeritus University of California, Riverside [email protected] <http://web.chem.ucsb.edu/~neuman/orgchembyneuman/> Chapter Outline of the Book ************************************************************************************** I. Foundations 1. Organic Molecules and Chemical Bonding 2. Alkanes and Cycloalkanes 3. Haloalkanes, Alcohols, Ethers, and Amines 4. Stereochemistry 5. Organic Spectrometry II. Reactions, Mechanisms, Multiple Bonds 6. Organic Reactions *(Not yet Posted) 7. Reactions of Haloalkanes, Alcohols, and Amines. Nucleophilic Substitution 8. Alkenes and Alkynes 9. Formation of Alkenes and Alkynes. Elimination Reactions 10. Alkenes and Alkynes. Addition Reactions 11. Free Radical Addition and Substitution Reactions III. Conjugation, Electronic Effects, Carbonyl Groups 12. Conjugated and Aromatic Molecules 13. Carbonyl Compounds. Ketones, Aldehydes, and Carboxylic Acids 14. Substituent Effects 15. Carbonyl Compounds. Esters, Amides, and Related Molecules IV. Carbonyl and Pericyclic Reactions and Mechanisms 16. Carbonyl Compounds. Addition and Substitution Reactions 17. Oxidation and Reduction Reactions 18. Reactions of Enolate Ions and Enols 19. Cyclization and Pericyclic Reactions *(Not yet Posted) V. Bioorganic Compounds 20. Carbohydrates 21. Lipids 22. Peptides, Proteins, and α−Amino Acids 23. Nucleic Acids ************************************************************************************** -
Alternative Biochemistries for Alien Life: Basic Concepts and Requirements for the Design of a Robust Biocontainment System in Genetic Isolation
G C A T T A C G G C A T genes Review Alternative Biochemistries for Alien Life: Basic Concepts and Requirements for the Design of a Robust Biocontainment System in Genetic Isolation Christian Diwo 1 and Nediljko Budisa 1,2,* 1 Institut für Chemie, Technische Universität Berlin Müller-Breslau-Straße 10, 10623 Berlin, Germany; [email protected] 2 Department of Chemistry, University of Manitoba, 144 Dysart Rd, 360 Parker Building, Winnipeg, MB R3T 2N2, Canada * Correspondence: [email protected] or [email protected]; Tel.: +49-30-314-28821 or +1-204-474-9178 Received: 27 November 2018; Accepted: 21 December 2018; Published: 28 December 2018 Abstract: The universal genetic code, which is the foundation of cellular organization for almost all organisms, has fostered the exchange of genetic information from very different paths of evolution. The result of this communication network of potentially beneficial traits can be observed as modern biodiversity. Today, the genetic modification techniques of synthetic biology allow for the design of specialized organisms and their employment as tools, creating an artificial biodiversity based on the same universal genetic code. As there is no natural barrier towards the proliferation of genetic information which confers an advantage for a certain species, the naturally evolved genetic pool could be irreversibly altered if modified genetic information is exchanged. We argue that an alien genetic code which is incompatible with nature is likely to assure the inhibition of all mechanisms of genetic information transfer in an open environment. The two conceivable routes to synthetic life are either de novo cellular design or the successive alienation of a complex biological organism through laboratory evolution. -
Polymer Exemption Guidance Manual POLYMER EXEMPTION GUIDANCE MANUAL
United States Office of Pollution EPA 744-B-97-001 Environmental Protection Prevention and Toxics June 1997 Agency (7406) Polymer Exemption Guidance Manual POLYMER EXEMPTION GUIDANCE MANUAL 5/22/97 A technical manual to accompany, but not supersede the "Premanufacture Notification Exemptions; Revisions of Exemptions for Polymers; Final Rule" found at 40 CFR Part 723, (60) FR 16316-16336, published Wednesday, March 29, 1995 Environmental Protection Agency Office of Pollution Prevention and Toxics 401 M St., SW., Washington, DC 20460-0001 Copies of this document are available through the TSCA Assistance Information Service at (202) 554-1404 or by faxing requests to (202) 554-5603. TABLE OF CONTENTS LIST OF EQUATIONS............................ ii LIST OF FIGURES............................. ii LIST OF TABLES ............................. ii 1. INTRODUCTION ............................ 1 2. HISTORY............................... 2 3. DEFINITIONS............................. 3 4. ELIGIBILITY REQUIREMENTS ...................... 4 4.1. MEETING THE DEFINITION OF A POLYMER AT 40 CFR §723.250(b)... 5 4.2. SUBSTANCES EXCLUDED FROM THE EXEMPTION AT 40 CFR §723.250(d) . 7 4.2.1. EXCLUSIONS FOR CATIONIC AND POTENTIALLY CATIONIC POLYMERS ....................... 8 4.2.1.1. CATIONIC POLYMERS NOT EXCLUDED FROM EXEMPTION 8 4.2.2. EXCLUSIONS FOR ELEMENTAL CRITERIA........... 9 4.2.3. EXCLUSIONS FOR DEGRADABLE OR UNSTABLE POLYMERS .... 9 4.2.4. EXCLUSIONS BY REACTANTS................ 9 4.2.5. EXCLUSIONS FOR WATER-ABSORBING POLYMERS........ 10 4.3. CATEGORIES WHICH ARE NO LONGER EXCLUDED FROM EXEMPTION .... 10 4.4. MEETING EXEMPTION CRITERIA AT 40 CFR §723.250(e) ....... 10 4.4.1. THE (e)(1) EXEMPTION CRITERIA............. 10 4.4.1.1. LOW-CONCERN FUNCTIONAL GROUPS AND THE (e)(1) EXEMPTION................. -
United States Patent Office Patented Oct
3,346,562 United States Patent Office Patented Oct. 10, 1967 2 3,346,562 cg METHOD FOR THE PRODUCTION OF PO-CE Base RBONUCLEOSDE-5'-PHOSPHATE / O Mikio Honjo, Takatsuki, and Ryuji Maremoto, Minoo, Cl EO Japan, assignors to Takeda Chemical industries, Ltd., Osaka, Japan No Drawing. Filed May 31, 1966, Ser. No. 553,718 Claims priority, application Japan, May 29, 1965, R. X R. 40/31,814 9 Claims. (Cl. 260-21.5) HO. O. BIO O 10 N1 N1 This invention is concerned with a method for the pro Po-H, Base Po-H, Base duction of ribonucleoside-5'-phosphate. EIO k" wE+ EO k". Ribonucleoside-5'-phosphate is very useful as condi H HO - ment for food and also in the pharmaceutical industry, O O OH OH and has been chemically produced by at first protecting 15 X the hydroxyl groups at the 2'- and 3'-positions of its ribose R1 R2 moiety with acyl or isopropylidene groups and then phos phorylating the 5'-hydroxyl group of the thus-protected RN compound with pentavalent phosphorus compound such C=O: aliphatic ketone or aromatic aldehyde as phosphorus pentachloride, phosphorus oxychloride, 20 R?2 etc., followed by removing the protecting groups. As "ribonucleoside' in the present method there are However, this hitherto-known method requires a long used those containing purine base such as adenosine, time (about 7 to about 30 hours) for completing the pro inosine, etc. or those containing pyrimidine base such as tection and phosphorylation, and therefore is not desirable uridine, cytidine, etc. As the aliphatic ketone having 3 from an industrial viewpoint. -
Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells
Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells William N. Kelley, James B. Wyngaarden J Clin Invest. 1970;49(3):602-609. https://doi.org/10.1172/JCI106271. Research Article In the present study we have examined the effects of allopurinol and oxipurinol on thed e novo synthesis of purines in cultured human fibroblasts. Allopurinol inhibits de novo purine synthesis in the absence of xanthine oxidase. Inhibition at lower concentrations of the drug requires the presence of hypoxanthine-guanine phosphoribosyltransferase as it does in vivo. Although this suggests that the inhibitory effect of allopurinol at least at the lower concentrations tested is a consequence of its conversion to the ribonucleotide form in human cells, the nucleotide derivative could not be demonstrated. Several possible indirect consequences of such a conversion were also sought. There was no evidence that allopurinol was further utilized in the synthesis of nucleic acids in these cultured human cells and no effect of either allopurinol or oxipurinol on the long-term survival of human cells in vitro could be demonstrated. At higher concentrations, both allopurinol and oxipurinol inhibit the early steps ofd e novo purine synthesis in the absence of either xanthine oxidase or hypoxanthine-guanine phosphoribosyltransferase. This indicates that at higher drug concentrations, inhibition is occurring by some mechanism other than those previously postulated. Find the latest version: https://jci.me/106271/pdf Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells WILLIAM N. KELLEY and JAMES B. WYNGAARDEN From the Division of Metabolic and Genetic Diseases, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27706 A B S TR A C T In the present study we have examined the de novo synthesis of purines in many patients. -
Competitive Inhibition of Beef Heart Cyclic AMP Phosphodiesterase by Cytokinins and Related Compounds (Cyclic AMP Metabolism/Intracellular Cyclic AMP Concentration)
Proc. Nat. Acad. Sci. USA Vol. 71, No. 12, pp. 4670-4674, December 1974 Competitive Inhibition of Beef Heart Cyclic AMP Phosphodiesterase by Cytokinins and Related Compounds (cyclic AMP metabolism/intracellular cyclic AMP concentration) SIDNEY M. HECHT*, ROBERT D. FAULKNER, AND S. D. HAWRELAK Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Mass. 02139 Communicated by Nelson J. Leonard, September 9, 1974 ABSTRACT Two cytokinins and four related analogs, also shown to contain detectable adenylate cyclase activity, none of which is a cyclic ribonucleotide, have been shown suggesting that the cytokinins might function by raising the to act as competitive inhibitors of the high Km cyclic-AMP phosphodiesterase (3': 5'-cyclic-AMP 5'-nucleotidohydro- intracellular level of cyclic AMP (18). If operative in mouse lase, EC 3.1.4.1-7) activity from beef heart. Weak inhibition fibroblasts this phenomenon might also explain the observed of the low Km cyclic AMP phosphodiesterase activity was growth inhibition of such cells by cytokinins (S. M. Hecht and also observed, suggesting a possible mechanism for regula- R.. B. Frye, in preparation), since it has been shown that there tion of intracellular cyclic AMP levels by the exogenously added compounds. In addition to the kinetic data, ob- is an inverse relationship between intracellular cyclic AMP tained on the six inhibitors in four different heterocyclic concentration and growth in fibroblasts (19). series, 15 other cytokinins and related compounds have To further explore the apparent involvement of exogenously been shown to inhibit the high Km cyclic AMP phospho- added cytokinins in cyclic AMP metabolism, we have in- diesterase activity at single concentrations of substrate vestigated the kinetics of interaction of certain cytokinins, and and inhibitor. -
Geochemical Influences on Nonenzymatic Oligomerization Of
bioRxiv preprint doi: https://doi.org/10.1101/872234; this version posted December 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Geochemical influences on nonenzymatic oligomerization of prebiotically relevant cyclic nucleotides Authors: Shikha Dagar‡, Susovan Sarkar‡, Sudha Rajamani‡* ‡ Department of Biology, Indian Institute of Science Education and Research, Pune 411008, India Correspondence: [email protected]; Tel.: +91-20-2590-8061 Running title: Cyclic nucleotides and emergence of an RNA World Key words: Dehydration-rehydration cycles, lipid-assisted oligomerization, cyclic nucleotides, analogue environments Dagar, S. 1 bioRxiv preprint doi: https://doi.org/10.1101/872234; this version posted December 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The spontaneous emergence of RNA on the early Earth continues to remain an enigma in the field of origins of life. Few studies have looked at the nonenzymatic oligomerization of cyclic nucleotides under neutral to alkaline conditions, in fully dehydrated state. Herein, we systematically investigated the oligomerization of cyclic nucleotides under prebiotically relevant conditions, where starting reactants were subjected to repeated dehydration-rehydration (DH- RH) regimes, like they would have been on an early Earth. DH-RH conditions, a recurring geological theme, are driven by naturally occurring processes including diurnal cycles and tidal pool activity. These conditions have been shown to facilitate uphill oligomerization reactions in terrestrial geothermal niches, which are hypothesized to be pertinent sites for the emergence of life.